rs6999971

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_017780.4(CHD7):​c.6135G>A​(p.Pro2045Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0371 in 1,613,438 control chromosomes in the GnomAD database, including 1,318 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.030 ( 103 hom., cov: 32)
Exomes 𝑓: 0.038 ( 1215 hom. )

Consequence

CHD7
NM_017780.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:14

Conservation

PhyloP100: -2.15
Variant links:
Genes affected
CHD7 (HGNC:20626): (chromodomain helicase DNA binding protein 7) This gene encodes a protein that contains several helicase family domains. Mutations in this gene have been found in some patients with the CHARGE syndrome. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7).
BP6
Variant 8-60852860-G-A is Benign according to our data. Variant chr8-60852860-G-A is described in ClinVar as [Benign]. Clinvar id is 158306.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-60852860-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-2.15 with no splicing effect.
BA1
GnomAdExome4 highest subpopulation (MID) allele frequency at 95% confidence interval = 0.0528 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CHD7NM_017780.4 linkuse as main transcriptc.6135G>A p.Pro2045Pro synonymous_variant 31/38 ENST00000423902.7 NP_060250.2 Q9P2D1-1Q6ZWF9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CHD7ENST00000423902.7 linkuse as main transcriptc.6135G>A p.Pro2045Pro synonymous_variant 31/385 NM_017780.4 ENSP00000392028.1 Q9P2D1-1
CHD7ENST00000524602.5 linkuse as main transcriptc.1717-9369G>A intron_variant 1 ENSP00000437061.1 Q9P2D1-4
CHD7ENST00000695853.1 linkuse as main transcriptn.6135G>A non_coding_transcript_exon_variant 31/37 ENSP00000512218.1 A0A8Q3WKT9

Frequencies

GnomAD3 genomes
AF:
0.0301
AC:
4581
AN:
152062
Hom.:
103
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00945
Gnomad AMI
AF:
0.0987
Gnomad AMR
AF:
0.0303
Gnomad ASJ
AF:
0.0761
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00975
Gnomad FIN
AF:
0.0467
Gnomad MID
AF:
0.0665
Gnomad NFE
AF:
0.0400
Gnomad OTH
AF:
0.0445
GnomAD3 exomes
AF:
0.0310
AC:
7722
AN:
249082
Hom.:
169
AF XY:
0.0312
AC XY:
4217
AN XY:
135140
show subpopulations
Gnomad AFR exome
AF:
0.00846
Gnomad AMR exome
AF:
0.0240
Gnomad ASJ exome
AF:
0.0726
Gnomad EAS exome
AF:
0.0000556
Gnomad SAS exome
AF:
0.0101
Gnomad FIN exome
AF:
0.0441
Gnomad NFE exome
AF:
0.0400
Gnomad OTH exome
AF:
0.0418
GnomAD4 exome
AF:
0.0378
AC:
55294
AN:
1461258
Hom.:
1215
Cov.:
33
AF XY:
0.0372
AC XY:
27054
AN XY:
726810
show subpopulations
Gnomad4 AFR exome
AF:
0.00914
Gnomad4 AMR exome
AF:
0.0248
Gnomad4 ASJ exome
AF:
0.0698
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0105
Gnomad4 FIN exome
AF:
0.0413
Gnomad4 NFE exome
AF:
0.0418
Gnomad4 OTH exome
AF:
0.0348
GnomAD4 genome
AF:
0.0301
AC:
4579
AN:
152180
Hom.:
103
Cov.:
32
AF XY:
0.0297
AC XY:
2206
AN XY:
74396
show subpopulations
Gnomad4 AFR
AF:
0.00942
Gnomad4 AMR
AF:
0.0302
Gnomad4 ASJ
AF:
0.0761
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00997
Gnomad4 FIN
AF:
0.0467
Gnomad4 NFE
AF:
0.0400
Gnomad4 OTH
AF:
0.0441
Alfa
AF:
0.0335
Hom.:
78
Bravo
AF:
0.0283
Asia WGS
AF:
0.00433
AC:
16
AN:
3478
EpiCase
AF:
0.0451
EpiControl
AF:
0.0443

ClinVar

Significance: Benign
Submissions summary: Benign:14
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:7
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jun 11, 2014- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoFeb 08, 2013- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineAug 23, 2017p.Pro2045Pro in exon 31 of CHD7: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue, is not located with in the splice consensus sequence, and has been identified in 4.35% (288/6614) of Finnish chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broa dinstitute.org; dbSNP rs6999971). -
not provided Benign:4
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2015- -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesMay 03, 2020- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsMar 02, 2018- -
CHARGE syndrome Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsMar 24, 2016This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Hypogonadotropic hypogonadism 5 with or without anosmia Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.70
CADD
Benign
8.0
DANN
Benign
0.76

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs6999971; hg19: chr8-61765419; COSMIC: COSV71110571; COSMIC: COSV71110571; API